Mono Pharmacare Past Earnings Performance
We're still processing the latest earnings report of this company
Past criteria checks 4/6
Mono Pharmacare has been growing earnings at an average annual rate of 52.9%, while the Healthcare industry saw earnings growing at 23.2% annually. Revenues have been growing at an average rate of 42% per year. Mono Pharmacare's return on equity is 8.7%, and it has net margins of 2%.
Key information
52.9%
Earnings growth rate
42.7%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | 42.0% |
| Return on equity | 8.7% |
| Net Margin | 2.0% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
No updates
Revenue & Expenses Breakdown
How Mono Pharmacare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 1,224 | 24 | 35 | 0 |
| 31 Dec 23 | 950 | 24 | 32 | 0 |
| 30 Sep 23 | 762 | 22 | 26 | 0 |
| 30 Jun 23 | 547 | 16 | 18 | 0 |
| 31 Mar 23 | 331 | 9 | 10 | 0 |
| 31 Mar 22 | 371 | 4 | 7 | 0 |
| 31 Mar 21 | 284 | 1 | 7 | 0 |
| 31 Mar 20 | 117 | 0 | 10 | 0 |
Quality Earnings: MONOPHARMA has high quality earnings.
Growing Profit Margin: MONOPHARMA's current net profit margins (2%) are lower than last year (2.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MONOPHARMA's earnings have grown significantly by 52.9% per year over the past 5 years.
Accelerating Growth: MONOPHARMA's earnings growth over the past year (158.8%) exceeds its 5-year average (52.9% per year).
Earnings vs Industry: MONOPHARMA earnings growth over the past year (158.8%) exceeded the Healthcare industry 33.2%.
Return on Equity
High ROE: MONOPHARMA's Return on Equity (8.7%) is considered low.